Related Experiment Video
Updated: Jun 6, 2026

05:54
Real-Time Dynamic Navigation System for the Precise Quad-Zygomatic Implant Placement in a Patient with a Severely Atrophic Maxilla
Published on: October 18, 2021
Zygomatic metastasis from breast cancer
Matteo Brucoli1, Francesco Arcuri, Livia Stellin
1Department of Maxillo-Facial Surgery Azienda Ospedaliera Maggiore della Carità University of Piemonte Orientale Amedeo Avogadro, Novara, Italy.
The Journal of Craniofacial Surgery
|December 2, 2010
Summary
This study reports a rare case of breast cancer metastasis to the zygomatic bone (malar region). This finding highlights unusual metastatic patterns of breast cancer in the maxillofacial area.
Area of Science:
- Oncology
- Maxillofacial Surgery
- Pathology
Background:
- Breast cancer is the second most common cancer in women, with an 11% lifetime risk in the US.
- Metastases to the maxillofacial (MF) region are rare (1% of MF malignancies), often indicating a poor prognosis.
- Common MF sites for metastasis include the mandible, maxilla, and salivary glands; the zygoma is an exceptionally rare site.
Purpose of the Study:
- To document a unique case of breast cancer metastasis to the zygomatic bone.
- To contribute to the understanding of atypical metastatic patterns of breast cancer in the head and neck region.
Main Methods:
- Case report of a solitary mass in the right zygoma.
- Histopathological examination confirmed metastasis from breast cancer.
Main Results:
- A solitary mass in the right zygoma was diagnosed as breast cancer metastasis.
- This represents the first reported case of breast cancer metastasis specifically to the malar bone (zygoma).
- Literature review identified only four other cases of metastasis to the zygomatic complex from other primary cancers (lung, rectum, liver, uterine).
Conclusions:
- The zygomatic bone is an extremely rare site for breast cancer metastasis.
- This case expands the known spectrum of atypical metastatic locations for breast cancer in the maxillofacial region.
- Awareness of such unusual presentations is crucial for accurate diagnosis and management of metastatic breast cancer.
Related Concept Videos
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

